跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Squro 200 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Squro 200
Approved
STANDARD
Squro 200
Intas Pharmaceuticals Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
5fb86f0a6c7d99d5
Company
Intas Pharmaceuticals Limited
Type
Standard
Approval Details
Approval Id
5fb86f0a6c7d99d5
Drug Approval Philippines Name
Squro 200
Product Name
Squro 200
Registration Number
DRP-10612
Brand Name
Squro 200
Generic Name
Quetiapine (as fumarate)
Dosage Form
Film-Coated Sustained-Release Tablet
Dosage Strength
200 mg
Manufacturer
Intas Pharmaceuticals Limited
Importer
Accord Healthcare Limited - Philippine Branch Office
Distributor
Accord Healthcare Limited - Philippine Branch Office
Company Detail Path
/organization/intas-pharmaceuticals-limited
Issuance Date
26 October 2021
Expiry Date
26 October 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
5fb86f0a6c7d99d5
Type
Standard
Back to Philippines FDA Approvals